Calcitonin and carcinoembryonic antigen in poorly differentiated follicular carcinoma
- 1 June 1982
- Vol. 49 (11), 2342-2348
- https://doi.org/10.1002/1097-0142(19820601)49:11<2342::aid-cncr2820491122>3.0.co;2-1
Abstract
Previous studies have shown that certain patients suffering from poorly differentiated follicular carcinoma (PDFC) of the thyroid had high levels of calcitonin (CT) and carcinoembryonic antigen (CEA) in the plasma. In this work, both CT and CEA were localized in tissue sections obtained at operation from patients suffering from PDFC. The results confirm the hypothesis that certain cases of PDFC are in fact CT-secreting tumors and represent another type of thyroid neoplasma. Patients suffering from PDFC should be screened using both CT and CEA assays.This publication has 17 references indexed in Scilit:
- CEA and non‐specific cross‐reacting antigen (NCA) in medullary carcinomas of the thyroidInternational Journal of Cancer, 1979
- Plasma carcinoembryonic antigen versus plasma calcitonin in the diagnosis of medullary carcinoma of the thyroidCancer Immunology, Immunotherapy, 1978
- Association of medullary carcinoma of the thyroid with carcinoembryonic antigenBritish Journal of Cancer, 1976
- HYPERSECRETION OF CALCITONIN IN NEOPLASTIC CONDITIONSThe Lancet, 1974
- C-cell thyroid adenoma in manThe Journal of Pathology, 1971
- THE UNLABELED ANTIBODY ENZYME METHOD OF IMMUNOHISTOCHEMISTRY PREPARATION AND PROPERTIES OF SOLUBLE ANTIGEN-ANTIBODY COMPLEX (HORSERADISH PEROXIDASE-ANTIHORSERADISH PEROXIDASE) AND ITS USE IN IDENTIFICATION OF SPIROCHETESJournal of Histochemistry & Cytochemistry, 1970
- Medullary Carcinoma of the Thyroid GlandNew England Journal of Medicine, 1968
- A CALCITONIN-SECRETING THYROID CARCINOMAThe Lancet, 1968
- Pathological and clinical findings in a series of 67 cases of medullary carcinoma of the thyroidJournal of Clinical Pathology, 1966
- MEDULLARY (SOLID) CARCINOMA OF THE THYROID—A CLINICOPATHOLOGIC ENTITY*Journal of Clinical Endocrinology & Metabolism, 1959